NGNE Insider Trading - Neurogene Inc.

발행주식수	15,801,901 shares
내부자 지분	8,617,263 shares
내부자 주주	54.53 %
전체 내부자	44

내부자 센티멘트 점수

내부자 센티멘트 점수를 통해서 내부자들이 법인 지분을 매입하는 기업들에 대해서 알아볼 수 있습니다.

이는 내부자의 누적도가 가장 높은 기업을 식별하는 정교하고 복합적인 지수를 분석하는 계량 모델의 결과 값입니다. 스코어링 모델은 이전 90일 동안 매수한 "내부자의 순 숫자", "매수한 주식의 총합", "내부자가 소유한 주식의 총합"의 조합을 사용합니다. 점수는 0에서 100 사이이며, 점수가 높을수록 피어(Peer: 동종업계 경쟁기업)에 대한 누적도가 높다는 것을 나타내며, 평균은 50입니다.

업데이트 주기: 일별

내부자의 누적도가 가장 높은 기업 목록을 확인할 수 있는 내부자들의 최다 선택(Insiders Top Picks)을 참고하십시오.

가장 높은 순위의 주식을 확인하세요

내부 경영진 센티멘트 점수

내부 경영진 센티멘트 점수를 통해서 내부 경영진들이 법인 지분을 매입하는 기업들에 대해서 알아볼 수 있습니다.

내부 거래의 정의에 따라 내부 경영진(기업 임원)도 내부자이지만, 다른 내부자(10% 주주 및 이사회 구성원)들과는 달리 내부 경영진은 매일 회사에서 근무하며, 거래 시에 자신의 자금을 사용합니다. (많은 경우에 10% 주주 및 이사회 구성원은 다른 사람의 자금을 관리하는 자금 관리자입니다.) 따라서 내부 경영진(기업 임원: Officer)의 내부 거래는 훨씬 더 중요하며 올바른 분석이 필요합니다.

내부자 센티멘트 점수와 마찬가지로 임원 감정 점수는 가장 높은 수준의 임원 축적을 가진 기업을 식별하는 정교하고 복합적인 지수 퀀트(Multi-factor quantitative) 모델의 결과입니다.

업데이트 주기: 일별

내부자의 누적도가 가장 높은 기업 목록을 확인할 수 있는 내부자들의 최다 선택(Insiders Top Picks)을 참고하십시오.

가장 높은 순위의 주식을 확인하세요

주요 내부자 지표

이 수치는 해당 기업이 다양한 내부자 지표에 따라 어떻게 순위를 매겨지는 지를 설명합니다. 백분위 순위는 이 기업이 미국 시장의 다른 기업들과 어떻게 비교되는지 보여줍니다. 순위가 높을수록 더 나은 상황에 있다는 것을 의미합니다.

예를 들어, 일반적으로 내부자의 매입은 긍정적인 지표라고 간주되어지기 때문에, 내부자의 매입(내부자의 매각, 역시도)가 적은 기업보다 내부자의 매입이 많은 기업은 순위가 높을 것입니다.

내부자의 순 매입(순위)

-4 ( )

10447 out of 10948

내부자의 순 매입(Net Number of Insiders Buying)는 내부자 매수의 총 수에서 지난 90일 동안의 내부자 매도의 총 수를 뺀 값입니다. 여기에 백분위 순위가 표시됩니다(범위: 0~100%).

내부자가 매입한 플로트 비율 (순위)

-0.452% ( )

10495 out of 10786

"내부자가 매입한 플로트 비율(Percent of Float Bought by Insiders)"은 내부자가 매입한 주식의 총 수에서 내부자가 매도한 주식의 총 수를 뺀 값을 전체 플로트로 나눈 값에 100을 곱한 값입니다. * ((내부자가 매입한 주식의 총 수 - 내부자가 매도한 주식의 총 수) ÷ 전체 플로트) x 100

내부자 트레이딩 차트

Neurogene Inc. 내부자의 매매 거래는 아래 차트에 나와 있습니다. 내부자들은 기업의 임원(내부 경영진), 이사 또는 주요 투자자입니다. 일반적으로 내부자가 중요한 비공개 정보를 기반으로 자신이 속한 기업을 거래하는 것은 불법으로 간주됩니다. 이것은 내부자가 자신의 기업 내에서 행하는 모든 거래가 불법이라는 것을 뜻은 아닙니다. 그러나 그들은 자신들의 모든 거래를 양식 4를 통해 SEC에 보고해야만 합니다.

내부자의 명단 및 이익 지표

아래 표는 공개된 내부자의 목록이며, SEC에 공개된 제출 문서에서 자동으로 생성됩니다. "이름", "가장 최근의 직급", "이사, 임원 또는 10% 주주"에 대한 지정 외에도 최근에 공개된 보유 주식에 대한 정보를 보여줍니다. 또한 가능한 경우 내부자의 과거 거래 실적도 확인 가능합니다. 과거 거래 실적은 내부자가 실제 "공개 시장"(Open market) 매입 거래를 수행한 실적을 가중 평균한 값입니다. 이 계산 방법에 대한 자세한 내용은 유튜브 웨비나 를 참조하시면 됩니다.

See our leaderboard of most profitable insider traders.

내부자	소유 지분	주식 분할
Kamran Alam CFO, Vice President Finance - [O]	0	0
Baker Bros. Advisors Lp Director, 10% Owner - [D] [10%]	1,658,190	1,658,190
Julian Baker 10% Owner - [10%]	3,501,691	1,658,190
Martin Babler	25,000
Baker Bros. Advisors (GP) LLC 10% Owner - [10%]	25,000	1,658,190
Meta Cantey Boyd	0
Gary Bridger Director - [D]	0	0
Stuart Cobb Chief Scientific Officer - [O]	30,497	30,497
Donna Cochener	400,000
Christine Mikail Cvijic President and CFO, Director - [D] [O]	93,640	93,640
Jonathan G Drachman President and CEO, Director - [D] [O]	100,000	20,000
Jeremy Green 10% Owner - [10%]	4,041,211	808,242
Robert Ho Chief Financial Officer - [O]	21,503	4,301
& Johnson Johnson 10% Owner - [10%]	100,000	100,000

내부자	소유 지분	주식 분할
Abigail Jenkins Chief Commercial Officer - [O]	0	0
Johnson & Johnson Innovation - JJDC, Inc. 10% Owner - [10%]	100,000	100,000
Elaine V Jones Director - [D]	0	0
Julie Jordan Chief Medical Officer - [O]	12,472	12,472
Daniel J Levitt Director - [D]	0	0
Erin Lavelle	25,000
Lavelle Erin M.	0
Richard S Levy	0
Lloyd MacKenzie Chief Operating Officer - [O]	0	0
David Main President and CEO, Director - [D] [O]	71,530	71,530
Shelley McCloskey VP, HR and Administration - [O]	0	0
Rachel McMinn Chief Executive Officer, Director - [D] [O]	1,344,307	1,344,307
David Chilton Mitchell VP Global Regulatory & Quality - [O]	3,575	3,575
Kelvin Neu Director - [D]	72	72
Nolan Sean P.	25,000

내부자	소유 지분	주식 분할
Noonberg Sarah B.	25,000
Rohan Palekar	25,000
Pfizer Inc 10% Owner - [10%]	975,403	975,403
Priti Patel -	37,313	7,463
Robert Pelzer	15,000
Redmile Group, LLC 10% Owner - [10%]	4,041,211	808,242
Stephen B Shrewsbury CMO; Senior VP Clinical Dev. - [O]	400	400
Todd E Simpson Director - [D]	0	0
Samsara BioCapital GP, LLC 10% Owner - [10%]	1,668,357	1,668,357
Sean Michael Smith Interim CFO, Prin Acct Off - [O]	21,637	4,327
Barbara Troupin Chief Medical Officer - [O]	0	0
Holly Vance	100,000
Ventures West 8 Limited Partnership 10% Owner - [10%]	1,543,989	1,543,989
Carl Walkey Senior Vice President - [O]	1,352,489	270,498
Lewis T Williams	25,000

Report errors via our new Insider Auditing Tool

내부자의 매입 내역 추적: 단기 이익 분석

이 섹션에서는 NGNE / Neurogene Inc.에서 계획되지 않은 "공개 시장"(Open market)의 내부자가 매입한 모든 상품의 수익성을 분석합니다. 이 분석을 통해서 내부자가 비정상적인 수익을 지속적으로 창출하는지 파악하는 데 도움이 되며, 이러한 분석은 수행해볼 가치가 있습니다. 이 분석은 개별 거래 후 1년 동안 수행한 것이며, 결과는 이론 값입니다. .

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 "공개 시장"(Open market)에서의 매입을 보여줍니다.

거래일	내부자	보고된 지분	보고된 가격	조정된 지분	조정된 가격	가격 기준	최고까지 일수	최고에서 가격	최고 이익 ($)	최고 수익률 (%)
2024-11-26	Samsara BioCapital GP, LLC	2,000	27.5000	2,000	27.5000	55,000	323	34.3700	13,740	24.98
2024-11-26	Samsara BioCapital GP, LLC	15,219	26.7300	15,219	26.7300	406,804
2024-11-26	Samsara BioCapital GP, LLC	10,803	26.0100	10,803	26.0100	280,986
2024-11-26	Samsara BioCapital GP, LLC	20,748	24.9100	20,748	24.9100	516,833
2024-11-22	McMinn Rachel	47,500	20.4000	47,500	20.4000	969,000
2024-11-22	Cvijic Christine Mikail	24,000	20.4750	24,000	20.4750	491,400
2023-08-17	BAKER BROS. ADVISORS LP	7,676	0.6924	1,535	3.4620	5,315
2023-08-17	BAKER BROS. ADVISORS LP	93,091	0.6924	18,618	3.4620	64,456
2023-08-17	BAKER BROS. ADVISORS LP	5,041	0.6928	1,008	3.4640	3,492

조정된 가격은 분할 조정 가격입니다. 조정된 지분은 분할 조정 지분입니다.

내부자 매매의 실적: 단기 손실 분석

이 섹선에서는 NGNE / Neurogene Inc.에서 이루어진 "공개 시장(Open market)"에서의 모든 계획되지 않은 내부자 매매의 단기 손실 회피(Short-term loss avoidance)를 분석합니다. 일관된 손실 회피 패턴을 통해서 향후 매매 거래가 가격 하락을 초래할 수도 있음을 예상할 수 있습니다. 이 분석은 각 각 매매 거래 후 1년 동안의 자료이며, 결과는 이론 값입니다. .

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 공개 시장에서의 매매를 보여줍니다.

거래일	내부자	보고된 지분	보고된 가격	조정된 지분	조정된 가격	가격 기준	최저까지 일수	최저에서 가격	회피된 최대 손실($)	회피된 최대 손실율(%)
2026-03-26	McMinn Rachel	3,352	22.0749	3,352	22.0749	73,995	18	19.2800	-9,368	-12.66
2026-03-26	Jordan Julie	828	21.8932	828	21.8932	18,128
2026-03-26	Cvijic Christine Mikail	2,558	21.6247	2,558	21.6247	55,316
2026-03-13	Cvijic Christine Mikail	263	22.0195	263	22.0195	5,791
2026-03-13	Cvijic Christine Mikail	1,395	21.2451	1,395	21.2451	29,637
2026-03-13	Cvijic Christine Mikail	2,387	20.4224	2,387	20.4224	48,748
2025-03-13	Cvijic Christine Mikail	4,501	16.9400	4,501	16.9400	76,247
2023-08-11	Smith Sean Michael	1,323	0.6184	265	3.0920	818
2023-04-03	Patel Priti	3,769	0.6919	754	3.4595	2,608

조정된 가격은 분할 조정 가격입니다. 조정된 지분은 분할 조정 지분입니다.

거래 내역

전체 거래 내역을 보려면 링크 아이콘을 클릭하세요. 10b5-1 자동 거래 계획의 일부로 보고된 거래는 10b-5 열에 X 표시가 나타납니다.

보고일	거래일	양식	내부자	티커	증권 소유권	코드	직접	행사 가격	단위 가격	단위 변동	가치 변동 (단위: 1,000)	잔여 옵션	잔여 주식
2026-05-08	2026-05-06	4	Cvijic Christine Mikail	NGNE	Common Stock	S - Sale	D		32.4358	-4,800	-156		93,640
2026-05-08	2026-05-06	4	Cvijic Christine Mikail	NGNE	Common Stock	S - Sale	D		30.0732	-4,800	-144		98,440
2026-03-30	2026-03-26	4	Cvijic Christine Mikail	NGNE	Common Stock	S - Sale	D		21.6247	-2,558	-55		103,240
2026-03-30	2026-03-26	4	Jordan Julie	NGNE	Common Stock	S - Sale	D		21.8932	-828	-18		12,472
2026-03-30	2026-03-26	4	McMinn Rachel	NGNE	Common Stock	S - Sale	D		22.0749	-3,352	-74		1,344,307
2026-03-17	2026-03-13	4	Cvijic Christine Mikail	NGNE	Common Stock	S - Sale	D		22.0195	-263	-6		105,798
2026-03-17	2026-03-13	4	Cvijic Christine Mikail	NGNE	Common Stock	S - Sale	D		21.2451	-1,395	-30		106,061
2026-03-17	2026-03-13	4	Cvijic Christine Mikail	NGNE	Common Stock	S - Sale	D		20.4224	-2,387	-49		107,456
2026-03-17	2026-03-13	4	Cobb Stuart	NGNE	Common Stock	S - Sale	D		22.0800	-148	-3		30,497
2026-03-17	2026-03-13	4	Cobb Stuart	NGNE	Common Stock	S - Sale	D		21.3400	-2,658	-57		30,645
2026-03-17	2026-03-13	4	Cobb Stuart	NGNE	Common Stock	S - Sale	D		20.4100	-3,991	-81		33,303
2026-03-03	2026-02-27	4	Cvijic Christine Mikail	NGNE	Common Stock	S - Sale	D		25.1096	-4,800	-121		109,843
2026-02-24	2026-02-20	4	Cobb Stuart	NGNE	Common Stock	A - Award	D			16,500			37,294
2026-02-24	2026-02-20	4	Cvijic Christine Mikail	NGNE	Common Stock	A - Award	D			22,000			114,643
2026-02-24	2026-02-20	4	Jordan Julie	NGNE	Common Stock	A - Award	D			4,900			13,300
2026-02-24	2026-02-20	4	McMinn Rachel	NGNE	Common Stock	A - Award	D			25,900			1,347,659
2025-05-15	2025-05-14	4	Cobb Stuart	NGNE	Common Stock	S - Sale	D		15.1542	-6,797	-103		20,794
2025-03-28	2025-03-26	4	Cobb Stuart	NGNE	Common Stock	A - Award	D			7,200			27,591
2025-03-28	2025-03-26	4	Cvijic Christine Mikail	NGNE	Common Stock	A - Award	D			20,300			92,643
2025-03-28	2025-03-26	4	Jordan Julie	NGNE	Common Stock	A - Award	D			8,400			8,400
2025-03-28	2025-03-26	4	McMinn Rachel	NGNE	Common Stock	A - Award	D			23,900			1,274,259
2025-03-17	2025-03-13	4	Cvijic Christine Mikail	NGNE	Common Stock	S - Sale	D		16.9400	-4,501	-76		72,343
2024-11-27	2024-11-26	4	Samsara BioCapital GP, LLC By Samsara BioCapital, L.P.	NGNE	Common Stock	P - Purchase	I		27.5000	2,000	55		1,717,127
2024-11-27	2024-11-26	4	Samsara BioCapital GP, LLC By Samsara BioCapital, L.P.	NGNE	Common Stock	P - Purchase	I		26.7300	15,219	407		1,715,127
2024-11-27	2024-11-26	4	Samsara BioCapital GP, LLC By Samsara BioCapital, L.P.	NGNE	Common Stock	P - Purchase	I		26.0100	10,803	281		1,699,908
2024-11-27	2024-11-26	4	Samsara BioCapital GP, LLC By Samsara BioCapital, L.P.	NGNE	Common Stock	P - Purchase	I		24.9100	20,748	517		1,689,105
2024-11-27		3	Samsara BioCapital GP, LLC By Samsara BioCapital, L.P.	NGNE	Common Stock		I						1,668,357
2024-11-25	2024-11-22	4	McMinn Rachel	NGNE	Common Stock	P - Purchase	D		20.4000	47,500	969		1,297,859
2024-11-25	2024-11-22	4	Cvijic Christine Mikail	NGNE	Common Stock	P - Purchase	D		20.4750	24,000	491		76,844
2024-03-14	2024-03-13	4	Cvijic Christine Mikail	NGNE	Common Stock	A - Award	D			31,903			52,844
2024-03-14	2024-03-13	4	Cobb Stuart	NGNE	Common Stock	A - Award	D			20,391			20,391
2023-12-26		3	Cvijic Christine Mikail	NGNE	Common Stock		D						20,941
2023-12-26		3	McMinn Rachel	NGNE	Common Stock		D						1,250,359
2023-10-10	2023-10-05	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	X - Other	I			535,601			1,658,190
2023-10-10	2023-10-05	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	X - Other	I			57,049			155,874
2023-08-17	2023-08-17	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	P - Purchase	I		0.6928	61,134	42		5,612,949
2023-08-17	2023-08-17	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	P - Purchase	I		0.6928	5,041	3		494,133
2023-08-17	2023-08-17	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	P - Purchase	I		0.6924	93,091	64		5,551,815
2023-08-17	2023-08-17	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	P - Purchase	I		0.6924	7,676	5		489,092
2023-08-17	2023-08-16	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	P - Purchase	I		0.6828	4,434	3		5,458,724
2023-08-17	2023-08-16	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	P - Purchase	I		0.6828	366	0		481,416
2023-08-17	2023-08-16	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	P - Purchase	I		0.6805	207,676	141		5,454,290
2023-08-17	2023-08-16	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	P - Purchase	I		0.6805	17,124	12		481,050
2023-08-17	2023-08-15	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	P - Purchase	I		0.6650	4,342	3		5,246,614
2023-08-17	2023-08-15	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	P - Purchase	I		0.6650	358	0		463,926
2023-08-17	2023-08-15	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	P - Purchase	I		0.6308	1,740,581	1,098		5,242,272
2023-08-17	2023-08-15	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	P - Purchase	I		0.6308	143,519	91		463,568
2023-08-14	2023-08-11	4	Smith Sean Michael	NLTX	Common Stock	S - Sale	D		0.6184	-1,323	-1		21,637
2023-08-14	2023-08-10	4	Smith Sean Michael	NLTX	Common Stock	M - Exercise	D			5,000			22,960
2023-04-04	2023-04-03	4	Patel Priti	NLTX	Common Stock	S - Sale	D		0.6919	-3,769	-3		37,313
2023-04-04	2023-03-31	4	Patel Priti	NLTX	Common Stock	M - Exercise	D			10,000			41,082
2023-02-03	2023-02-02	4	Patel Priti	NLTX	Common Stock	S - Sale	D		0.5972	-14,380	-9		31,082
2023-02-03	2023-02-01	4	Patel Priti	NLTX	Common Stock	M - Exercise	D			35,000			45,462
2023-02-03	2023-02-02	4	Smith Sean Michael	NLTX	Common Stock	S - Sale	D		0.5972	-3,316	-2		15,960
2023-02-03	2023-02-01	4	Smith Sean Michael	NLTX	Common Stock	M - Exercise	D			12,500			19,276
2022-08-12	2022-08-10	4	Smith Sean Michael	NLTX	Common Stock	S - Sale	D		0.9914	-1,655	-2		6,776
2022-08-12	2022-08-10	4	Smith Sean Michael	NLTX	Common Stock	M - Exercise	D			5,000			8,431
2022-05-16	2022-05-12	4	SIMPSON TODD E	NLTX	Stock Option (Right to Buy)	A - Award	D	1.07		25,000		25,000
2022-05-16	2022-05-12	4	PALEKAR ROHAN	NLTX	Stock Option (Right to Buy)	A - Award	D	1.07		25,000		25,000
2022-05-16	2022-05-12	4	Lavelle Erin	NLTX	Stock Option (Right to Buy)	A - Award	D	1.07		25,000		25,000
2022-05-16	2022-05-12	4	Noonberg Sarah B.	NLTX	Stock Option (Right to Buy)	A - Award	D	1.07		25,000		25,000
2022-05-16	2022-05-12	4	Babler Martin	NLTX	Stock Option (Right to Buy)	A - Award	D	1.07		25,000		25,000
2022-05-16	2022-05-12	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Non-Qualified Stock Option (right to buy)	A - Award	I	1.07		25,000		25,000
2022-05-03	2022-05-02	4	Patel Priti	NLTX	Common Stock	S - Sale	D		1.2186	-5,538	-7		6,462
2022-05-03	2022-04-30	4	Patel Priti	NLTX	Restricted Stock Units	M - Exercise	D	0.00		10,000		10,000
2022-05-03	2022-04-30	4	Patel Priti	NLTX	Common Stock	M - Exercise	D			10,000			12,000
2022-03-15	2022-03-14	4	Cochener Donna	NLTX	Stock Option (Right to Buy)	A - Award	D	1.81		400,000		400,000
2022-03-04	2022-03-02	4	PALEKAR ROHAN	NLTX	Stock Option (Right to Buy)	A - Award	D	2.72		50,000		50,000
2022-03-03		3	Smith Sean Michael	NLTX	Common Stock		D						3,431
2022-03-03	2022-03-02	4	Smith Sean Michael	NLTX	Stock Option (Right to Buy)	A - Award	D	2.72		80,000		80,000
2022-02-14	2021-10-26	5	DRACHMAN JONATHAN G	NLTX	Common Stock	G - Gift	I			75,000			100,000
2022-02-14	2021-10-26	5	DRACHMAN JONATHAN G	NLTX	Common Stock	G - Gift	I			75,000			100,000
2022-02-14	2021-10-26	5	DRACHMAN JONATHAN G	NLTX	Common Stock	G - Gift	D			-75,000			2,198,686
2022-02-14	2021-10-26	5	DRACHMAN JONATHAN G	NLTX	Common Stock	G - Gift	D			-75,000			2,198,686
2022-02-02	2022-02-01	4	Walkey Carl	NLTX	Restricted Stock Units	A - Award	D	0.00		55,000		55,000
2022-02-02	2022-02-01	4	Patel Priti	NLTX	Restricted Stock Units	A - Award	D	0.00		70,000		70,000
2022-02-02	2022-02-01	4	Ho Robert	NLTX	Restricted Stock Units	A - Award	D	0.00		70,000		70,000
2021-08-26	2021-08-25	4	DRACHMAN JONATHAN G	NLTX	Common Stock	P - Purchase	I		6.4490	25,000	161		25,000
2021-08-26	2021-08-25	4	DRACHMAN JONATHAN G	NLTX	Common Stock	P - Purchase	I		6.4490	25,000	161		25,000
2021-08-26	2021-08-24	4	DRACHMAN JONATHAN G	NLTX	Common Stock	P - Purchase	D		6.1110	100,000	611		2,348,686
2021-08-05	2021-08-03	4	Walkey Carl	NLTX	Stock Option (Right to Buy)	A - Award	D	6.80		100,000		100,000
2021-08-05	2021-08-03	4	Vance Holly	NLTX	Stock Option (Right to Buy)	A - Award	D	6.80		100,000		100,000
2021-08-05	2021-08-03	4	Patel Priti	NLTX	Stock Option (Right to Buy)	A - Award	D	6.80		50,000		50,000
2021-08-05	2021-08-03	4	Ho Robert	NLTX	Stock Option (Right to Buy)	A - Award	D	6.80		190,000		190,000
2021-08-05	2021-08-03	4	DRACHMAN JONATHAN G	NLTX	Stock Option (Right to Buy)	A - Award	D	6.80		400,000		400,000
2021-06-17	2021-06-16	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		10.1900	-600	-6		1,352,489
2021-06-11	2021-06-09	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		10.8246	-650	-7		1,353,089
2021-06-09	2021-06-08	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		11.0000	-600	-7		1,353,739
2021-06-07	2021-06-04	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		10.0000	-600	-6		1,354,339
2021-06-07	2021-06-04	4	DRACHMAN JONATHAN G	NLTX	Common Stock	P - Purchase	D		9.6082	10,000	96		2,248,686
2021-06-07	2021-06-03	4	DRACHMAN JONATHAN G	NLTX	Common Stock	P - Purchase	D		9.4818	40,000	379		2,238,686
2021-05-26	2021-05-26	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		10.0000	-600	-6		1,354,939
2021-05-21	2021-05-19	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		10.6300	-600	-6		1,355,539
2021-05-13	2021-05-11	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Non-Qualified Stock Option (right to buy)	A - Award	I	11.40		25,000		25,000
2021-05-13	2021-05-11	4	Babler Martin	NLTX	Stock Option (Right to Buy)	A - Award	D	11.40		25,000		25,000
2021-05-13	2021-05-11	4	Lavelle Erin M.	NLTX	Stock Option (Right to Buy)	A - Award	D	11.40		25,000		25,000
2021-05-13	2021-05-11	4	Noonberg Sarah B.	NLTX	Stock Option (Right to Buy)	A - Award	D	11.40		25,000		25,000
2021-05-13	2021-05-11	4	Williams Lewis T	NLTX	Stock Option (Right to Buy)	A - Award	D	11.40		25,000		25,000
2021-05-13	2021-05-11	4	SIMPSON TODD E	NLTX	Stock Option (Right to Buy)	A - Award	D	11.40		25,000		25,000
2021-05-12	2021-05-12	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		11.0900	-1,200	-13		1,354,762
2021-05-06	2021-05-05	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		11.3000	-1,200	-14		1,355,962
2021-05-04	2021-04-30	4	Patel Priti	NLTX	Stock Option (Right to Buy)	A - Award	D	12.49		475,000		475,000
2021-05-04	2021-04-30	4	Patel Priti	NLTX	Restricted Stock Units	A - Award	D	0.00		20,000		20,000
2021-04-30	2021-04-28	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		12.5800	-2,400	-30		1,357,162
2021-04-27	2021-04-26	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		13.0000	-600	-8		1,359,562
2021-04-22	2021-04-21	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		11.9800	-1,800	-22		1,360,162
2021-04-16	2021-04-14	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		12.2200	-1,800	-22		1,361,962
2021-04-08	2021-04-07	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		12.0200	-1,800	-22		1,363,762
2021-04-06	2021-04-05	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		13.0000	-600	-8		1,365,562
2021-04-02	2021-03-31	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		11.9600	-1,800	-22		1,366,162
2021-03-24	2021-03-24	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		11.9533	-1,800	-22		1,367,962
2021-03-24	2021-03-22	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		12.0000	-600	-7		1,369,762
2021-03-18	2021-03-17	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		11.3600	-1,200	-14		1,370,362
2021-03-18	2021-03-17	4	Ho Robert	NLTX	Common Stock	S - Sale	D		11.0137	-6,497	-72		21,503
2021-03-18	2021-03-16	4	Ho Robert	NLTX	Restricted Stock Units	M - Exercise	D	0.00		25,000		50,000
2021-03-18	2021-03-16	4	Ho Robert	NLTX	Common Stock	M - Exercise	D			25,000			28,000
2021-03-11	2021-03-10	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		11.9667	-1,800	-22		1,371,562
2021-03-04	2021-03-03	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		11.8667	-1,800	-21		1,373,362
2021-02-25	2021-02-25	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		13.0000	-600	-8		1,375,162
2021-02-25	2021-02-24	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		12.1400	-1,800	-22		1,375,762
2021-02-18	2021-02-17	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		12.7000	-2,400	-30		1,377,562
2021-02-12	2021-02-10	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		14.2000	-3,000	-43		1,379,962
2021-02-09	2021-02-05	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		14.0000	-600	-8		1,382,962
2021-02-05	2021-02-03	4	Walkey Carl	NLTX	Common Stock	S - Sale	D		13.2300	-2,400	-32		1,383,562
2021-02-02	2021-01-30	4	Walkey Carl	NLTX	Stock Option (Right to Buy)	A - Award	D	12.60		45,000		45,000
2021-02-02		3	Walkey Carl	NLTX	Common Stock		D						1,385,962
2020-12-23	2020-07-07	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Pre-Funded Warrants	P - Purchase	I			518,555		10,283,888
2020-12-23	2020-07-07	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Pre-Funded Warrants	P - Purchase	I			38,974		1,199,122
2020-12-23	2020-07-07	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	P - Purchase	I		15.2500	394,360	6,014		3,501,691
2020-12-23	2020-07-07	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	P - Purchase	I		15.2500	29,640	452		320,049
2020-10-20	2020-10-19	4	Vance Holly	NLTX	Stock Option (Right to Buy)	A - Award	D	12.30		220,000		220,000
2020-09-10	2020-09-08	4	Babler Martin	NLTX	Stock Option (Right to Buy)	A - Award	D	12.25		50,000		50,000
2020-08-12	2020-08-10	4	DRACHMAN JONATHAN G	NLTX	Stock Option (Right to Buy)	A - Award	D	12.00		420,000		420,000
2020-08-12	2020-08-10	4	Ho Robert	NLTX	Stock Option (Right to Buy)	A - Award	D	12.00		90,000		90,000
2020-06-02	2020-06-01	4	Lavelle Erin M.	NLTX	Stock Option (Right to Buy)	A - Award	D	13.58		50,000		50,000
2020-05-07	2020-05-05	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Non-Qualified Stock Option (right to buy)	A - Award	I	12.84		25,000		25,000
2020-05-07	2020-05-05	4	Nolan Sean P.	NLTX	Stock Option (Right to Buy)	A - Award	D	12.84		25,000		25,000
2020-05-07	2020-05-05	4	Noonberg Sarah B.	NLTX	Stock Option (Right to Buy)	A - Award	D	12.84		25,000		25,000
2020-05-07	2020-05-05	4	SIMPSON TODD E	NLTX	Stock Option (Right to Buy)	A - Award	D	12.84		25,000		25,000
2020-05-07	2020-05-05	4	Williams Lewis T	NLTX	Stock Option (Right to Buy)	A - Award	D	12.84		25,000		25,000
2020-04-06	2020-04-02	4	Redmile Group, LLC	NLTX	Common Stock	S - Sale	I		11.8200	-100	-1		4,041,211
2020-04-06	2020-04-02	4	Redmile Group, LLC	NLTX	Common Stock	S - Sale	I		11.3039	-9,734	-110		4,041,311
2020-04-06	2020-04-02	4	Redmile Group, LLC	NLTX	Common Stock	P - Purchase	I		11.8506	1,000	12		4,051,045
2020-04-06	2020-04-02	4	Redmile Group, LLC	NLTX	Common Stock	P - Purchase	I		11.3605	38,300	435		4,050,045
2020-04-06	2020-04-01	4	Redmile Group, LLC	NLTX	Common Stock	S - Sale	I		11.8650	-200	-2		4,011,745
2020-04-06	2020-04-01	4	Redmile Group, LLC	NLTX	Common Stock	S - Sale	I		11.0616	-9,634	-107		4,011,945
2020-04-06	2020-04-01	4	Redmile Group, LLC	NLTX	Common Stock	P - Purchase	I		11.6517	9,000	105		4,021,579
2020-04-06	2020-04-01	4	Redmile Group, LLC	NLTX	Common Stock	P - Purchase	I		10.9482	33,500	367		4,012,579
2020-04-06	2020-03-31	4	Redmile Group, LLC	NLTX	Common Stock	P - Purchase	I		10.7079	7,500	80		3,979,079
2020-04-06	2020-03-31	4	Redmile Group, LLC	NLTX	Common Stock	P - Purchase	I		10.1813	22,500	229		3,971,579
2020-04-06	2020-03-30	4	Redmile Group, LLC	NLTX	Common Stock	P - Purchase	I		10.2744	2,700	28		3,949,079
2020-04-06	2020-03-30	4	Redmile Group, LLC	NLTX	Common Stock	P - Purchase	I		9.9050	29,800	295		3,946,379
2020-04-06	2020-03-27	4	Redmile Group, LLC	NLTX	Common Stock	P - Purchase	I		9.2079	50,000	460		3,916,579
2020-04-06		3	Green Jeremy	NLTX	Common Stock		I						7,733,158
2020-04-06		3	Green Jeremy	NLTX	Common Stock		I						7,733,158
2020-04-06		3	Green Jeremy	NLTX	Common Stock		I						7,733,158
2020-04-06		3	Green Jeremy	NLTX	Common Stock		I						7,733,158
2020-03-16		3	Ho Robert	NLTX	Common Stock		D						6,000
2020-03-16		3	Ho Robert	NLTX	Common Stock		D						6,000
2020-03-16		3	Ho Robert	NLTX	Common Stock		D						6,000
2020-03-16	2020-03-16	4	Ho Robert	NLTX	Stock Option (Right to Buy)	A - Award	D	6.44		200,000		200,000
2020-03-16	2020-03-16	4	Ho Robert	NLTX	Restricted Stock Units	A - Award	D	0.00		75,000		75,000
2019-12-20	2019-12-20	4	DRACHMAN JONATHAN G	NLTX	Common Stock	P - Purchase	D		8.4000	119,047	1,000		2,198,686
2019-12-20	2019-11-12	4	DRACHMAN JONATHAN G	NLTX	Common Stock	C - Conversion	D			1,261,600			2,079,639
2019-12-20	2019-11-12	4	DRACHMAN JONATHAN G	NLTX	Series A Preferred Stock	C - Conversion	D			-12,616			0
2019-12-20	2019-12-20	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Pre-funded Warrants	A - Award	I			9,765,333		9,765,333
2019-12-20	2019-12-20	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Pre-funded Warrants	A - Award	I			1,160,148		1,161,048
2019-12-20	2019-12-20	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	D - Sale to Issuer	I			-9,765,333			3,107,331
2019-12-20	2019-12-20	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	D - Sale to Issuer	I			-1,160,148			290,409
2019-12-20	2019-12-20	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	P - Purchase	I		8.4000	2,767,505	23,247		12,872,664
2019-12-20	2019-12-20	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Common Stock	P - Purchase	I		8.4000	250,037	2,100		1,450,557
2019-10-15	2019-10-10	4	BAKER BROS. ADVISORS LP See Footnotes	NLTX	Non-Qualified Stock Option (right to buy)	A - Award	I	2.82		22,000		22,000
2019-10-15	2019-10-10	4	Williams Lewis T	NLTX	Stock Option (right to buy)	A - Award	D	2.82		22,000		22,000
2019-10-15	2019-10-10	4	Nolan Sean P.	NLTX	Stock Option (right to buy)	A - Award	D	2.82		22,000		22,000
2019-10-15	2019-10-10	4	Noonberg Sarah B.	NLTX	Stock Option (right to buy)	A - Award	D	2.82		22,000		22,000
2019-10-15	2019-10-10	4	SIMPSON TODD E	NLTX	Stock Option (right to buy)	A - Award	D	2.82		22,000		22,000
2019-09-13	2019-08-08	4/A	DRACHMAN JONATHAN G	NLTX	Series A Preferred Stock	A - Award	D			12,616			12,616
2019-09-13	2019-08-08	4/A	DRACHMAN JONATHAN G	NLTX	Common Stock	A - Award	D			568,039			568,039
2019-09-11	2019-09-11	4	DRACHMAN JONATHAN G	NLTX	Common Stock	P - Purchase	D		3.2975	136,436	450		584,428
2019-09-11	2019-09-10	4	DRACHMAN JONATHAN G	NLTX	Common Stock	P - Purchase	D		3.0834	36,742	113		447,992
2019-09-11	2019-09-09	4	DRACHMAN JONATHAN G	NLTX	Common Stock	P - Purchase	D		2.8450	76,822	219		411,250
2019-09-04	2019-08-31	4	DRACHMAN JONATHAN G	NLTX	Stock Option (Right to Buy)	A - Award	D	2.80		1,650,000		1,650,000
2019-08-12	2019-08-08	4	DRACHMAN JONATHAN G	NLTX	Series A Preferred Stock	A - Award	D			7,428			7,428
2019-08-12	2019-08-08	4	DRACHMAN JONATHAN G	NLTX	Common Stock	A - Award	D			334,428			334,428
2019-08-08	2019-08-07	4	BAKER BROS. ADVISORS LP See footnotes	AQXP	Common Stock	P - Purchase	I		3.1529	50,436	159		10,105,159
2019-08-08	2019-08-07	4	BAKER BROS. ADVISORS LP See footnotes	AQXP	Common Stock	P - Purchase	I		3.1529	4,564	14		1,200,520
2019-08-08	2019-08-07	4	BAKER BROS. ADVISORS LP See footnotes	AQXP	Common Stock	P - Purchase	I		3.0244	209,382	633		10,054,723
2019-08-08	2019-08-07	4	BAKER BROS. ADVISORS LP See footnotes	AQXP	Common Stock	P - Purchase	I		3.0244	18,943	57		1,195,956
2019-08-08	2019-08-07	4	BAKER BROS. ADVISORS LP See footnotes	AQXP	Common Stock	P - Purchase	I		2.9576	5,869	17		9,845,341
2019-08-08	2019-08-07	4	BAKER BROS. ADVISORS LP See footnotes	AQXP	Common Stock	P - Purchase	I		2.9576	531	2		1,177,013
2019-08-08	2019-08-06	4	BAKER BROS. ADVISORS LP See footnotes	AQXP	Common Stock	P - Purchase	I		2.8469	65,568	187		9,839,472
2019-08-08	2019-08-06	4	BAKER BROS. ADVISORS LP See footnotes	AQXP	Common Stock	P - Purchase	I		2.8469	5,932	17		1,176,482
2019-08-08	2019-08-06	4	BAKER BROS. ADVISORS LP See footnotes	AQXP	Common Stock	P - Purchase	I		2.8328	9,445	27		9,773,904
2019-08-08	2019-08-06	4	BAKER BROS. ADVISORS LP See footnotes	AQXP	Common Stock	P - Purchase	I		2.8328	855	2		1,170,550
2018-08-09	2018-08-07	4	Alam Kamran	AQXP	Stock Option (Right to Buy)	A - Award	D	3.07		195,000		195,000
2018-08-09	2018-08-07	4	MacKenzie Lloyd	AQXP	Stock Option (Right to Buy)	A - Award	D	3.07		145,000		145,000
2018-08-09	2018-08-07	4	McCloskey Shelley	AQXP	Stock Option (Right to Buy)	A - Award	D	3.07		75,000		75,000
2018-08-09	2018-08-07	4	Main David	AQXP	Stock Option (Right to Buy)	A - Award	D	3.07		415,000		415,000
2018-05-16	2018-05-14	4	LEVITT DANIEL J	AQXP	Stock Option (Right to Buy)	M - Exercise	D	10.56		-3,906		0
2018-05-16	2018-05-14	4	LEVITT DANIEL J	AQXP	Common Stock	S - Sale	D		12.6700	-3,906	-49		0
2018-05-16	2018-05-14	4	LEVITT DANIEL J	AQXP	Common Stock	M - Exercise	D		10.5600	3,906	41		3,906
2018-05-09	2018-05-07	4	Pelzer Robert	AQXP	Stock Option (Right to Buy)	A - Award	D	13.10		15,000		15,000
2018-05-09	2018-05-07	4	SIMPSON TODD E	AQXP	Stock Option (Right to Buy)	A - Award	D	13.10		15,000		15,000
2018-05-09	2018-05-07	4	LEVITT DANIEL J	AQXP	Stock Option (Right to Buy)	A - Award	D	13.10		15,000		15,000
2018-05-09	2018-05-07	4	Nolan Sean P.	AQXP	Stock Option (Right to Buy)	A - Award	D	13.10		15,000		15,000
2018-05-09	2018-05-07	4	Bridger Gary	AQXP	Stock Option (Right to Buy)	A - Award	D	13.10		15,000		15,000
2018-05-09	2018-05-07	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Non-Qualified Stock Option (right to buy)	A - Award	I	13.10		30,000		30,000
2018-03-19	2018-03-15	4	MacKenzie Lloyd	AQXP	Stock Option (Right to Buy)	M - Exercise	D	10.56		-1,302		0
2018-03-19	2018-03-15	4	MacKenzie Lloyd	AQXP	Common Stock	S - Sale	D		14.6304	-1,302	-19		0
2018-03-19	2018-03-15	4	MacKenzie Lloyd	AQXP	Common Stock	M - Exercise	D		10.5600	1,302	14		1,302
2018-03-13	2018-03-09	4	Troupin Barbara	AQXP	Stock Option (Right to Buy)	A - Award	D	16.55		75,000		75,000
2018-03-13	2018-03-09	4	Alam Kamran	AQXP	Stock Option (Right to Buy)	A - Award	D	16.55		75,000		75,000
2018-03-13	2018-03-09	4	Jenkins Abigail	AQXP	Stock Option (Right to Buy)	A - Award	D	16.55		75,000		75,000
2018-03-13	2018-03-09	4	MacKenzie Lloyd	AQXP	Stock Option (Right to Buy)	A - Award	D	16.55		75,000		75,000
2018-03-13	2018-03-09	4	Main David	AQXP	Stock Option (Right to Buy)	A - Award	D	16.55		225,000		225,000
2018-03-13	2018-03-09	4	McCloskey Shelley	AQXP	Stock Option (Right to Buy)	A - Award	D	16.55		45,000		45,000
2017-06-05	2017-06-05	4	Main David	AQXP	Stock Option (Right to Buy)	M - Exercise	D	9.60		-3,625		0
2017-06-05	2017-06-05	4	Main David	AQXP	Common Stock	S - Sale	D		13.1575	-3,625	-48		71,530
2017-06-05	2017-06-05	4	Main David	AQXP	Common Stock	M - Exercise	D		9.6000	3,625	35		75,155
2017-06-05	2017-06-02	4	Main David	AQXP	Stock Option (Right to Buy(	M - Exercise	D	9.60		-6,000		3,625
2017-06-05	2017-06-02	4	Main David	AQXP	Common Stock	S - Sale	D		13.5933	-6,000	-82		71,530
2017-06-05	2017-06-02	4	Main David	AQXP	Common Stock	M - Exercise	D		9.6000	6,000	58		77,530
2017-06-05	2017-06-01	4	Main David	AQXP	Stock Option (Right to Buy)	M - Exercise	D	9.60		-6,000		9,625
2017-06-05	2017-06-01	4	Main David	AQXP	Common Stock	S - Sale	D		12.9980	-6,000	-78		71,530
2017-06-05	2017-06-01	4	Main David	AQXP	Common Stock	M - Exercise	D		9.6000	6,000	58		77,530
2017-05-10	2017-05-08	4	SIMPSON TODD E	AQXP	Stock Option (Right to Buy)	A - Award	D	13.74		9,000		9,000
2017-05-10	2017-05-08	4	Nolan Sean P.	AQXP	Stock Option (Right to Buy)	A - Award	D	13.74		9,000		9,000
2017-05-10	2017-05-08	4	Pelzer Robert	AQXP	Stock Option (Right to Buy)	A - Award	D	13.74		9,000		9,000
2017-05-10	2017-05-08	4	LEVITT DANIEL J	AQXP	Stock Option (Right to Buy)	A - Award	D	13.74		9,000		9,000
2017-05-10	2017-05-08	4	Bridger Gary	AQXP	Stock Option (Right to Buy)	A - Award	D	13.74		9,000		9,000
2017-05-09	2017-05-08	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Non-Qualified Stock Option (right to buy)	A - Award	I	13.74		36,000		36,000
2017-03-27		3	Neu Kelvin	AQXP	Common Stock		D						72
2017-03-27		3	Neu Kelvin	AQXP	Common Stock		D						72
2017-03-10	2017-03-08	4	McCloskey Shelley	AQXP	Stock Option (Right to Buy)	A - Award	D	17.35		30,000		30,000
2017-03-10	2017-03-08	4	Mitchell David Chilton	AQXP	Stock Option (Right to Buy)	A - Award	D	17.35		25,000		25,000
2017-03-10	2017-03-08	4	Troupin Barbara	AQXP	Stock Option (Right to Buy)	A - Award	D	17.35		40,000		40,000
2017-03-10	2017-03-08	4	MacKenzie Lloyd	AQXP	Stock Option (Right to Buy)	A - Award	D	17.35		50,000		50,000
2017-03-10	2017-03-08	4	Main David	AQXP	Stock Option (Right to Buy)	A - Award	D	17.35		185,000		185,000
2017-03-10	2017-03-08	4	Alam Kamran	AQXP	Stock Option (Right to Buy)	A - Award	D	17.35		80,000		80,000
2017-03-10	2017-03-08	4	Jenkins Abigail	AQXP	Stock Option (Right to Buy)	A - Award	D	17.35		80,000		80,000
2017-02-14	2016-01-10	5	McCloskey Shelley	AQXP	Stock Option (Right to Buy)	A - Award	D	10.09		35,000		35,000
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		17.7600	32,051	569		9,764,459
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		17.7600	3,389	60		1,169,695
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		17.5996	235,169	4,139		9,732,408
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		17.5996	24,871	438		1,166,306
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		16.3053	35,360	577		9,497,239
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		16.3053	3,739	61		1,141,435
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		15.6226	5,006	78		9,461,879
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		15.6226	529	8		1,137,696
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		15.1300	15,148	229		9,456,873
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		15.1300	1,602	24		1,137,167
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		16.1970	9,143	148		9,441,725
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		16.1970	967	16		1,135,565
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		15.3475	8,671	133		9,432,582
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		15.3475	917	14		1,134,598
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		16.8533	2,442	41		9,423,911
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		16.8533	258	4		1,133,681
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		15.3210	11,305	173		9,421,469
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		15.3210	1,195	18		1,133,423
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		16.7395	5,697	95		9,410,164
2017-01-09	2017-01-09	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		16.7395	603	10		1,132,228
2016-11-10	2016-11-08	4	Troupin Barbara	AQXP	Stock Option (Right to Buy)	A - Award	D	11.77		50,000		50,000
2016-10-06		3	Troupin Barbara	AQXP	No securities are benefically owned		D						0
2016-09-21	2016-09-20	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		13.1497	12,550	165		1,131,625
2016-09-21	2016-09-20	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		12.2500	2,476,348	30,335		9,404,467
2016-09-21	2016-09-20	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		12.2500	294,707	3,610		1,119,075
2016-08-05	2016-08-03	4	Jenkins Abigail	AQXP	Stock Option (Right to Buy)	A - Award	D	8.97		50,000		50,000
2016-06-15		3	Jenkins Abigail	AQXP	No securities are beneficially owned		D						0
2016-05-11	2016-05-09	4	LEVITT DANIEL J	AQXP	Stock Option (Right to Buy)	A - Award	D	7.73		7,500		7,500
2016-05-11	2016-05-09	4	SIMPSON TODD E	AQXP	Stock Option (Right to Buy)	A - Award	D	7.73		7,500		7,500
2016-05-11	2016-05-09	4	Pelzer Robert	AQXP	Stock Option (Right to Buy)	A - Award	D	7.73		7,500		7,500
2016-05-11	2016-05-09	4	Nolan Sean P.	AQXP	Stock Option (Right to Buy)	A - Award	D	7.73		7,500		7,500
2016-05-11	2016-05-09	4	Bridger Gary	AQXP	Stock Option (Right to Buy)	A - Award	D	7.73		7,500		7,500
2016-03-16	2016-03-16	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.1560	128,975	1,052		6,928,119
2016-03-16	2016-03-16	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.1560	14,046	115		824,368
2016-03-16	2016-03-16	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		7.9084	185,413	1,466		6,799,144
2016-03-16	2016-03-16	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		7.9084	20,192	160		810,322
2016-03-16	2016-03-16	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		7.6993	11,840	91		6,613,731
2016-03-16	2016-03-16	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		7.6993	1,289	10		790,130
2016-03-16	2016-03-15	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.0257	68,132	547		6,601,891
2016-03-16	2016-03-15	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.0257	7,420	60		788,841
2016-03-16	2016-03-15	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		7.8786	30,986	244		6,533,759
2016-03-16	2016-03-15	4	BAKER BROS. ADVISORS LP	AQXP	Common Stock	P - Purchase	I		7.8786	3,374	27		781,421
2016-03-14	2016-03-10	4	SHREWSBURY STEPHEN B	AQXP	Stock Option (Right to Buy)	A - Award	D	8.08		35,000		35,000
2016-03-14	2016-03-10	4	Main David	AQXP	Stock Option (Right to Buy)	A - Award	D	8.08		120,000		120,000
2016-03-14	2016-03-10	4	Alam Kamran	AQXP	Stock Option (Right to Buy)	A - Award	D	8.08		40,000		40,000
2016-03-14	2016-03-10	4	MacKenzie Lloyd	AQXP	Stock Option (Right to Buy)	A - Award	D	8.08		35,000		35,000
2016-03-14	2016-03-10	4	Mitchell David Chilton	AQXP	Stock Option (Right to Buy)	A - Award	D	8.08		25,000		25,000
2016-01-26	2016-01-26	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		10.9960	3,581	39		6,502,773
2016-01-26	2016-01-26	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		10.9960	395	4		778,047
2016-01-26	2016-01-26	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		10.8033	66,345	717		6,499,192
2016-01-26	2016-01-26	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		10.8033	7,318	79		777,652
2016-01-26	2016-01-25	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		11.2043	2,522	28		6,432,847
2016-01-26	2016-01-25	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		11.2043	278	3		770,334
2016-01-26	2016-01-25	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		10.9755	4,503	49		6,430,325
2016-01-26	2016-01-25	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		10.9755	497	5		770,056
2016-01-26	2016-01-25	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		11.2326	2,833	32		6,425,822
2016-01-26	2016-01-25	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		11.2326	312	4		769,559
2016-01-26	2016-01-22	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		10.6908	25,650	274		6,422,989
2016-01-26	2016-01-22	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		10.6908	2,810	30		769,247
2016-01-26	2016-01-22	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		10.6000	156	2		6,397,339
2016-01-26	2016-01-22	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		10.6000	17	0		766,437
2016-01-26	2016-01-22	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		10.6937	4,021	43		6,397,183
2016-01-26	2016-01-22	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		10.6937	440	5		766,420
2016-01-26	2016-01-22	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		10.7814	17,221	186		6,393,162
2016-01-26	2016-01-22	4	BAKER BROS. ADVISORS LP	AQXP	Common Stock	P - Purchase	I		10.7814	1,887	20		765,980
2016-01-20	2016-01-20	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.9000	1,734	15		6,375,941
2016-01-20	2016-01-20	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.9000	190	2		764,093
2016-01-20	2016-01-20	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.9572	27,996	251		6,374,207
2016-01-20	2016-01-20	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.9572	3,067	27		763,903
2016-01-20	2016-01-20	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.9559	13,789	123		6,346,211
2016-01-20	2016-01-20	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.9559	1,511	14		760,836
2016-01-20	2016-01-20	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		9.8852	57,453	568		6,332,422
2016-01-20	2016-01-20	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		9.8852	6,294	62		759,325
2016-01-20	2016-01-19	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		9.1537	14,313	131		6,274,969
2016-01-20	2016-01-19	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		9.1537	1,568	14		753,031
2016-01-20	2016-01-19	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		9.2149	10,123	93		6,260,656
2016-01-20	2016-01-19	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		9.2149	1,109	10		751,463
2016-01-20	2016-01-19	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		9.0757	45,903	417		6,250,533
2016-01-20	2016-01-19	4	BAKER BROS. ADVISORS LP	AQXP	Common Stock	P - Purchase	I		9.0757	5,029	46		750,354
2016-01-15	2016-01-15	4/A	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.5591	47,193	404		6,204,630
2016-01-15	2016-01-15	4/A	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.5591	5,196	44		745,325
2016-01-15	2016-01-15	4/A	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.9529	4,949	44		6,157,437
2016-01-15	2016-01-15	4/A	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.9529	545	5		740,129
2016-01-15	2016-01-15	4/A	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.8249	3,279	29		6,152,488
2016-01-15	2016-01-15	4/A	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.8249	361	3		739,584
2016-01-15	2016-01-15	4/A	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.0999	20,851	169		6,149,209
2016-01-15	2016-01-15	4/A	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.0999	2,296	19		739,223
2016-01-15	2016-01-14	4/A	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.0764	2,998	24		6,128,358
2016-01-15	2016-01-14	4/A	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.0764	330	3		736,927
2016-01-15	2016-01-14	4/A	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		7.9110	12,706	101		6,125,360
2016-01-15	2016-01-14	4/A	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		7.9110	1,399	11		736,597
2016-01-15	2016-01-14	4/A	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.1717	90,550	740		6,112,654
2016-01-15	2016-01-14	4/A	BAKER BROS. ADVISORS LP	AQXP	Common Stock	P - Purchase	I		8.1717	9,970	81		735,198
2016-01-15	2016-01-15	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.5591	47,193	404		6,204,630
2016-01-15	2016-01-15	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.5591	5,196	44		745,325
2016-01-15	2016-01-15	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.9529	4,949	44		6,157,437
2016-01-15	2016-01-15	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.9529	545	5		740,129
2016-01-15	2016-01-15	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.8249	3,279	29		6,152,488
2016-01-15	2016-01-15	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.8249	361	3		739,584
2016-01-15	2016-01-15	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.0999	20,851	169		6,149,209
2016-01-15	2016-01-15	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.0999	2,296	19		739,223
2016-01-15	2016-01-14	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.0764	2,998	24		6,128,358
2016-01-15	2016-01-14	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.0764	330	3		736,927
2016-01-15	2016-01-14	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		7.9110	12,706	101		6,125,360
2016-01-15	2016-01-14	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		7.9110	1,399	11		736,597
2016-01-15	2016-01-14	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		8.1717	90,550	740		6,112,654
2016-01-15	2016-01-14	4	BAKER BROS. ADVISORS LP	AQXP	Common Stock	P - Purchase	I		8.1717	9,970	81		735,198
2015-12-23		3	McCloskey Shelley	AQXP	No securities are beneficially owned		D						0
2015-11-03	2015-10-31	4	Bridger Gary	AQXP	Common Stock	J - Other	I			-1,543,989			0
2015-09-11	2015-09-10	4	BAKER BROS. ADVISORS LP See Footnotes	AQXP	Common Stock	P - Purchase	I		15.5000	2,213,469	34,309		6,022,104
2015-09-11	2015-09-10	4	BAKER BROS. ADVISORS LP	AQXP	Common Stock	P - Purchase	I		15.5000	266,563	4,132		725,228
2015-08-26	2015-08-24	4	Mitchell David Chilton By spouse	AQXP	Common Stock	P - Purchase	I		17.8100	3,575	64		3,575
2015-08-14	2015-08-12	4	MacKenzie Lloyd	AQXP	Stock Option (Right to Buy)	M - Exercise	D	5.76		28,075		1,872
2015-08-14	2015-08-12	4	MacKenzie Lloyd	AQXP	Stock Option (Right to Buy)	M - Exercise	D	5.76		7,812		0
2015-08-14	2015-08-12	4	MacKenzie Lloyd	AQXP	Common Stock	S - Sale	D		18.6700	-35,887	-670		0
2015-08-14	2015-08-12	4	MacKenzie Lloyd	AQXP	Common Stock	M - Exercise	D		5.7600	28,075	162		35,887
2015-08-14	2015-08-12	4	MacKenzie Lloyd	AQXP	Common Stock	M - Exercise	D		5.7600	7,812	45		7,812
2015-08-14	2015-08-12	4	Alam Kamran	AQXP	Stock Option (Right to Buy)	M - Exercise	D	5.76		-20,833		0
2015-08-14	2015-08-12	4	Alam Kamran	AQXP	Stock Option (Right to Buy)	M - Exercise	D	5.76		-8,246		2,170
2015-08-14	2015-08-12	4	Alam Kamran	AQXP	Common Stock	S - Sale	D		18.6700	-29,079	-543		0
2015-08-14	2015-08-12	4	Alam Kamran	AQXP	Common Stock	M - Exercise	D		5.7600	20,833	120		29,079
2015-08-14	2015-08-12	4	Alam Kamran	AQXP	Common Stock	M - Exercise	D		5.7600	8,246	47		8,246
2015-08-13	2015-08-11	4	Mitchell David Chilton	AQXP	Common Stock	P - Purchase	D		24.3600	1,600	39		1,600
2015-08-12	2015-08-10	4	PFIZER INC	AQXP	Common Stock	S - Sale	D		23.4112	-58,632	-1,373		975,403
2015-08-12	2015-08-10	4	PFIZER INC	AQXP	Common Stock	S - Sale	D		22.5994	-44,268	-1,000		1,034,035
2015-08-12	2015-08-10	4	PFIZER INC	AQXP	Common Stock	S - Sale	D		24.3129	-31,400	-763		1,078,303
2015-08-12	2015-08-10	4	PFIZER INC	AQXP	Common Stock	S - Sale	D		20.3476	-25,931	-528		1,109,703
2015-08-12	2015-08-10	4	PFIZER INC	AQXP	Common Stock	S - Sale	D		26.3213	-13,109	-345		1,135,634
2015-08-12	2015-08-10	4	PFIZER INC	AQXP	Common Stock	S - Sale	D		25.3233	-12,726	-322		1,148,743
2015-08-12	2015-08-10	4	PFIZER INC	AQXP	Common Stock	S - Sale	D		38.4947	-11,627	-448		1,161,469
2015-08-12	2015-08-10	4	PFIZER INC	AQXP	Common Stock	S - Sale	D		36.3687	-10,544	-383		1,173,096
2015-08-12	2015-08-10	4	PFIZER INC	AQXP	Common Stock	S - Sale	D		37.2264	-9,901	-369		1,183,640
2015-08-12	2015-08-10	4	PFIZER INC	AQXP	Common Stock	S - Sale	D		39.5172	-9,142	-361		1,193,541
2015-08-12	2015-08-10	4	PFIZER INC	AQXP	Common Stock	S - Sale	D		21.4506	-8,969	-192		1,202,683
2015-08-12	2015-08-10	4	PFIZER INC	AQXP	Common Stock	S - Sale	D		27.3561	-8,565	-234		1,211,652
2015-08-12	2015-08-10	4	PFIZER INC	AQXP	Common Stock	S - Sale	D		40.2955	-6,073	-245		1,220,217
2015-08-12	2015-08-10	4	PFIZER INC	AQXP	Common Stock	S - Sale	D		35.6072	-3,207	-114		1,226,290
2015-08-12	2015-08-10	4	PFIZER INC	AQXP	Common Stock	S - Sale	D		28.4670	-2,975	-85		1,229,497
2015-08-12	2015-08-10	4	PFIZER INC	AQXP	Common Stock	S - Sale	D		41.2475	-2,840	-117		1,232,472
2015-08-12	2015-08-10	4	PFIZER INC	AQXP	Common Stock	S - Sale	D		29.0000	-18	-1		1,235,312
2015-08-12	2015-08-11	4	JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC, Inc.	AQXP	Common Stock	S - Sale	I		20.7400	-1,283,366	-26,617		100,000
2015-08-12	2015-08-10	4	JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC, Inc.	AQXP	Common Stock	S - Sale	I		31.6600	-231,455	-7,328		1,383,366
2015-08-10		3/A	BAKER FELIX	AQXP	Common Stock		D						2,260
2015-08-10		3/A	BAKER FELIX	AQXP	Common Stock		D						2,260
2015-08-10		3	667, L.P.	AQXP	Common Stock		I						8,075,935
2015-08-10		3	667, L.P.	AQXP	Common Stock		I						4,725,965
2015-08-10		3	667, L.P.	AQXP	Common Stock		I						8,075,935
2015-08-10		3	667, L.P.	AQXP	Common Stock		I						8,075,935
2015-08-10		3	667, L.P.	AQXP	Common Stock		I						4,725,965
2015-08-10		3	667, L.P.	AQXP	Common Stock		I						4,725,965
2015-08-10		3	667, L.P.	AQXP	Common Stock		I						4,725,965
2015-08-10		3	667, L.P.	AQXP	Common Stock		I						8,075,935
2015-08-10		3	667, L.P.	AQXP	Common Stock		I						4,725,965
2015-08-10		3	667, L.P.	AQXP	Common Stock		I						8,075,935
2015-08-10		3	667, L.P.	AQXP	Common Stock		I						4,725,965
2015-08-10		3	667, L.P.	AQXP	Common Stock		I						4,725,965
2015-08-10		3	667, L.P.	AQXP	Common Stock		I						8,075,935
2015-08-10		3	667, L.P.	AQXP	Common Stock		I						8,075,935
2015-03-16	2015-03-12	4	SHREWSBURY STEPHEN B	AQXP	Stock Option (Right to Buy)	A - Award	D	12.03		25,000		25,000
2015-03-16	2015-03-12	4	Nolan Sean P.	AQXP	Stock Option (Right to Buy)	A - Award	D	12.03		10,000		10,000
2015-03-16	2015-03-12	4	Main David	AQXP	Stock Option (Right to Buy)	A - Award	D	12.03		65,000		65,000
2015-03-16	2015-03-12	4	Pelzer Robert	AQXP	Stock Option (Right to Buy)	A - Award	D	12.03		5,000		5,000
2015-03-16	2015-03-12	4	SIMPSON TODD E	AQXP	Stock Option (Right to Buy)	A - Award	D	12.03		5,000		5,000
2015-03-16	2015-03-12	4	MacKenzie Lloyd	AQXP	Stock Option (Right to Buy)	A - Award	D	12.03		25,000		25,000
2015-03-16	2015-03-12	4	LEVITT DANIEL J	AQXP	Stock Option (Right to Buy)	A - Award	D	12.03		5,000		5,000
2015-03-16	2015-03-12	4	Bridger Gary	AQXP	Stock Option (Right to Buy)	A - Award	D	12.03		5,000		5,000
2015-03-16	2015-03-12	4	Alam Kamran	AQXP	Stock Option (Right to Buy)	A - Award	D	12.03		25,000		25,000
2015-02-09	2014-09-02	5	SHREWSBURY STEPHEN B	AQXP	Common Stock	P - Purchase	D		8.2200	400	3		400
2015-02-03	2014-03-12	4/A	JOHNSON & JOHNSON By Johnson & Johnson Development Corporation	AQXP	Series C Preferred Stock	C - Conversion	I			-379,543		0
2015-02-03	2014-03-12	4/A	JOHNSON & JOHNSON By Johnson & Johnson Development Corporation	AQXP	Series B-2 Preferred Stock	C - Conversion	I			-292,532		0
2015-02-03	2014-03-12	4/A	JOHNSON & JOHNSON By Johnson & Johnson Development Corporation	AQXP	Series B-1 Preferred Stock	C - Conversion	I			-293,884		0
2015-02-03	2014-03-12	4/A	JOHNSON & JOHNSON By Johnson & Johnson Development Corporation	AQXP	Series A-2 Preferred Stock	C - Conversion	I			-170,454		0
2015-02-03	2014-03-12	4/A	JOHNSON & JOHNSON By Johnson & Johnson Development Corporation	AQXP	Series A-1 Preferred Stock	C - Conversion	I			-255,681		0
2015-02-03	2014-03-12	4/A	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	P - Purchase	I		11.0000	272,727	3,000		1,664,821
2015-02-03	2014-03-12	4/A	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	C - Conversion	I			1,392,094			1,392,094
2015-01-13	2015-01-11	4	Mitchell David Chilton	AQXP	Stock Option (Right to Buy)	A - Award	D	9.51		35,000		35,000
2014-12-18	2014-12-17	4	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	S - Sale	I		7.5800	-1,593	-12		1,342,094
2014-12-18	2014-12-16	4	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	S - Sale	I		7.6300	-6,507	-50		1,343,687
2014-12-15	2014-12-12	4	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	S - Sale	I		7.5100	-3,645	-27		1,350,194
2014-12-15	2014-12-11	4	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	S - Sale	I		7.5000	-1,355	-10		1,353,839
2014-12-10	2014-12-10	4	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	S - Sale	I		7.7000	-1,300	-10		1,355,194
2014-12-10	2014-12-09	4	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	S - Sale	I		7.7300	-5,000	-39		1,356,494
2014-12-10	2014-12-08	4	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	S - Sale	I		7.6900	-2,000	-15		1,361,494
2014-12-05	2014-12-05	4	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	S - Sale	I		7.7800	-4,200	-33		1,363,494
2014-12-05	2014-12-04	4	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	S - Sale	I		7.7600	-10,073	-78		1,367,694
2014-12-05	2014-12-03	4	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	S - Sale	I		7.7500	-1,627	-13		1,377,767
2014-12-03	2014-12-01	4	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	S - Sale	I		7.5400	-1,200	-9		1,379,394
2014-11-26	2014-11-26	4	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	S - Sale	I		7.6000	-500	-4		1,380,594
2014-11-26	2014-11-25	4	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	S - Sale	I		7.8000	-1,500	-12		1,381,094
2014-11-24	2014-11-24	4	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	S - Sale	I		8.0200	-4,000	-32		1,382,594
2014-11-24	2014-11-21	4	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	S - Sale	I		8.2500	-2,400	-20		1,386,594
2014-11-24	2014-11-20	4	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	S - Sale	I		8.2100	-3,100	-25		1,388,994
2014-05-12	2014-05-08	4	SHREWSBURY STEPHEN B	AQXP	Stock Option (Right to Buy)	A - Award	D	10.10		31,250		31,250
2014-05-12	2014-05-08	4	Main David	AQXP	Stock Option (Right to Buy)	A - Award	D	10.10		65,000		65,000
2014-05-12	2014-05-08	4	Alam Kamran	AQXP	Stock Option (Right to Buy)	A - Award	D	10.10		31,250		31,250
2014-05-12	2014-05-08	4	MacKenzie Lloyd	AQXP	Stock Option (Right to Buy)	A - Award	D	10.10		25,000		25,000
2014-03-14	2014-03-12	4	Main David	AQXP	Common Exchangeable Shares	C - Conversion	D			-71,530		0
2014-03-14	2014-03-12	4	Main David	AQXP	Common Exchangeable Shares	D - Sale to Issuer	D		11.0000	-9,459	-104	0
2014-03-14	2014-03-12	4	Main David	AQXP	Common Stock	C - Conversion	D			71,530			71,530
2014-03-14	2014-03-12	4	Main David	AQXP	Common Special Voting Stock	C - Conversion	D			-71,530			0
2014-03-14	2014-03-12	4	Main David	AQXP	Common Special Voting Stock	D - Sale to Issuer	D		11.0000	-9,459	-104		71,530
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series C Exchangeable Shares	C - Conversion	D			-378,786		0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series C Preferred Stock	C - Conversion	D			-378,786		0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series C Preferred Stock	C - Conversion	D			378,786		0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series B-2 Exchangeable Shares	C - Conversion	D			-325,035		0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series B-2 Preferred Stock	C - Conversion	D			-325,035		0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series B-2 Preferred Stock	C - Conversion	D			325,035		0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series B-1 Exchangeable Shares	C - Conversion	D			-326,538		0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series B-1 Preferred Stock	C - Conversion	D			-326,538		0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series B-1 Preferred Stock	C - Conversion	D			326,538		0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series A-2 Preferred Stock	C - Conversion	D			-189,393		0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series A-2 Exchangeable Shares	C - Conversion	D			-189,393		0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series A-2 Preferred Stock	C - Conversion	D			189,393		0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series A-1 Exchangeable Shares	C - Conversion	D			-284,090		0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series A-1 Preferred Stock	C - Conversion	D			-284,090		0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series A-1 Preferred Stock	C - Conversion	D			284,090		0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Common Exchangeable Shares	C - Conversion	D			-40,147		0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Common Exchangeable Shares	A - Award	D		11.0000	36,502	402	40,147
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Common Stock	C - Conversion	D			1,543,989			1,543,989
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series C Special Voting Stock	D - Sale to Issuer	D			-378,786			0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series B-2 Special Voting Stock	D - Sale to Issuer	D			-325,035			0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series B-1 Special Voting Stock	D - Sale to Issuer	D			-326,538			0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series A-2 Special Voting Stock	D - Sale to Issuer	D			-189,393			0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Series A-1 Special Voting Stock	D - Sale to Issuer	D			-284,090			0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Common Special Voting Stock	D - Sale to Issuer	D			-40,147			0
2014-03-14	2014-03-12	4	Ventures West 8 Limited Partnership	AQXP	Common Special Voting Stock	A - Award	D			36,502			40,147
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series C Preferred Stock	C - Conversion	I			-378,786		0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series C Exchangeable Shares	C - Conversion	I			-378,786		0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series C Preferred Stock	C - Conversion	I			378,786		0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series B-2 Preferred Stock	C - Conversion	I			-325,035		0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series B-2 Exchangeable Shares	C - Conversion	I			-325,035		0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series B-2 Preferred Stock	C - Conversion	I			325,035		0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series B-1 Preferred Stock	C - Conversion	I			-326,538		0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series B-1 Exchangeable Shares	C - Conversion	I			-326,538		0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series B-1 Preferred Stock	C - Conversion	I			326,538		0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series A-2 Preferred Stock	C - Conversion	I			-189,393		0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series A-2 Exchangeable Shares	C - Conversion	I			-189,393		0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series A-2 Preferred Stock	C - Conversion	I			189,393		0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series A-1 Exchangeable Shares	C - Conversion	I			-284,090		0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series A-1 Preferred Stock	C - Conversion	I			-284,090		0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series A-1 Preferred Stock	C - Conversion	I			284,090		0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Common Exchangeable Shares	C - Conversion	I			-40,147		0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Common Exchangeable Shares	A - Award	I		11.0000	36,502	402	40,147
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Common Stock	C - Conversion	I			1,543,989			1,543,989
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series C Special Voting Stock	D - Sale to Issuer	I			-378,786			0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series B-2 Special Voting Stock	D - Sale to Issuer	I			-325,035			0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series B-1 Special Voting Stock	D - Sale to Issuer	I			-326,538			0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series A-2 Special Voting Stock	D - Sale to Issuer	I			-189,393			0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Series A-1 Special Voting Stock	D - Sale to Issuer	I			-284,090			0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Common Special Voting Stock	D - Sale to Issuer	I			-40,147			0
2014-03-14	2014-03-12	4	Bridger Gary See Note	AQXP	Common Special Voting Stock	A - Award	I			36,502			40,147
2014-03-14	2014-03-12	4	PFIZER INC	AQXP	Series C Preferred Stock	C - Conversion	D			-301,005		0
2014-03-14	2014-03-12	4	PFIZER INC	AQXP	Series B-2 Preferred Stock	C - Conversion	D			-327,178		0
2014-03-14	2014-03-12	4	PFIZER INC	AQXP	Series B-1 Preferred Stock	C - Conversion	D			-334,420		0
2014-03-14	2014-03-12	4	PFIZER INC	AQXP	Common Stock	P - Purchase	D		11.0000	272,727	3,000		1,235,330
2014-03-14	2014-03-12	4	PFIZER INC	AQXP	Common Stock	C - Conversion	D			962,603			962,603
2014-03-12	2014-03-12	4	JOHNSON & JOHNSON By Johnson & Johnson Development Corporation	AQXP	Series C Preferred Stock	C - Conversion	I			-379,543		0
2014-03-12	2014-03-12	4	JOHNSON & JOHNSON By Johnson & Johnson Development Corporation	AQXP	Series B-2 Preferred Stock	C - Conversion	I			-292,532		0
2014-03-12	2014-03-12	4	JOHNSON & JOHNSON By Johnson & Johnson Development Corporation	AQXP	Series B-1 Preferred Stock	C - Conversion	I			-293,884		0
2014-03-12	2014-03-12	4	JOHNSON & JOHNSON By Johnson & Johnson Development Corporation	AQXP	Series A-2 Preferred Stock	C - Conversion	I			-170,454		0
2014-03-12	2014-03-12	4	JOHNSON & JOHNSON By Johnson & Johnson Development Corporation	AQXP	Series A-1 Preferred Stock	C - Conversion	I			-255,681		0
2014-03-12	2014-03-12	4	JOHNSON & JOHNSON Johnson & Johnson Development Corporation	AQXP	Common Stock	C - Conversion	I			1,392,094			1,392,094
2014-03-10	2014-03-06	4	SIMPSON TODD E	AQXP	Stock Option (Right to Buy)	A - Award	D	11.00		8,333		8,333
2014-03-10	2014-03-06	4	Pelzer Robert	AQXP	Stock Option (Right to Buy)	A - Award	D	11.00		8,333		14,843
2014-03-10	2014-03-06	4	LEVITT DANIEL J	AQXP	Stock Option (Right to Buy)	A - Award	D	11.00		8,333		20,051
2014-03-10	2014-03-06	4	Bridger Gary	AQXP	Stock Option (Right to Buy)	A - Award	D	11.00		8,333		8,333
2014-03-06		3	Jones Elaine V	AQXP	No securities are beneficially owned		D						0
2014-03-06		3	SIMPSON TODD E	AQXP	No securities are beneficially owned		D						0
2014-03-06		3	Main David	AQXP	Common Special Voting Stock		D						161,978
2014-03-06		3	Main David	AQXP	Common Special Voting Stock		D						161,978
2014-03-06		3	Ventures West 8 Limited Partnership	AQXP	Common Special Voting Stock		D						1,511,132
2014-03-06		3	Ventures West 8 Limited Partnership	AQXP	Series A- Special Voting Stock		D						1,791,577
2014-03-06		3	Ventures West 8 Limited Partnership	AQXP	Series A-2 Special Voting Stock		D						1,696,880
2014-03-06		3	Ventures West 8 Limited Partnership	AQXP	Series B-1 Special Voting Stock		D						1,834,025
2014-03-06		3	Ventures West 8 Limited Partnership	AQXP	Series B-2 Special Voting Stock		D						1,832,522
2014-03-06		3	Ventures West 8 Limited Partnership	AQXP	Common Special Voting Stock		D						1,511,132
2014-03-06		3	Ventures West 8 Limited Partnership	AQXP	Series A- Special Voting Stock		D						1,791,577
2014-03-06		3	Ventures West 8 Limited Partnership	AQXP	Series A-2 Special Voting Stock		D						1,696,880
2014-03-06		3	Ventures West 8 Limited Partnership	AQXP	Series B-1 Special Voting Stock		D						1,834,025
2014-03-06		3	Ventures West 8 Limited Partnership	AQXP	Series B-2 Special Voting Stock		D						1,832,522
2014-03-06		3	Ventures West 8 Limited Partnership	AQXP	Series C Special Voting Stock		D						1,886,273
2014-03-06		3	Ventures West 8 Limited Partnership	AQXP	Series C Special Voting Stock		D						1,886,273
2014-03-06		3	Bridger Gary See Note (9)	AQXP	Series C Special Voting Stock		I						1,886,273
2014-03-06		3	Bridger Gary See Note (9)	AQXP	Series C Special Voting Stock		I						1,886,273
2014-03-06		3	Bridger Gary See Note (9)	AQXP	Series B-2 Special Voting Stock		I						1,832,522
2014-03-06		3	Bridger Gary See Note (9)	AQXP	Series B-1 Special Voting Stock		I						1,834,025
2014-03-06		3	Bridger Gary See Note (9)	AQXP	Series A-1 Special Voting Stock		I						1,791,577
2014-03-06		3	Bridger Gary See Note (9)	AQXP	Common Special Voting Stock		I						1,511,132
2014-03-06		3	Bridger Gary See Note (9)	AQXP	Series A-2 Special Voting Stock		I						1,696,880
2014-03-06		3	Bridger Gary See Note (9)	AQXP	Series A-2 Special Voting Stock		I						1,696,880
2014-03-06		3	Bridger Gary See Note (9)	AQXP	Series A-1 Special Voting Stock		I						1,791,577
2014-03-06		3	Bridger Gary See Note (9)	AQXP	Common Special Voting Stock		I						1,511,132
2014-03-06		3	Bridger Gary See Note (9)	AQXP	Series B-1 Special Voting Stock		I						1,834,025
2014-03-06		3	Bridger Gary See Note (9)	AQXP	Series B-2 Special Voting Stock		I						1,832,522

공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입

공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각

자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득

파생상품 전환

자사에게 유가증권을 매각 또는 양도

기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급

내부자에 의한 또는 내부자에게 증권 증여

지분스왑 및 유사 위험 회피거래

자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환

보고서 양식 4에 자진 신고된 거래

기타 (거래 내용을 설명하는 각주와 동반)

NGNE / Neurogene Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5